"Alrijne Leiderdorp is een gastvrij regioziekenhuis met poliklinieken, een diagnostisch centrum, verpleegafdelingen, operatiekamers, een Intensive Care, dagverpleging, kinderafdeling, spoedpost en een apotheek. Vrijwel alle medisch specialismen zijn aanwezig en wij hebben een uitgebreid aanbod aan onderzoeken en behandelingen. Zo heeft u alle zorg bij elkaar onder één dak. Bovendien werken wij samen met huisartsen en andere zorgverleners buiten het ziekenhuis en met specialisten in academische ziekenhuizen. Het ziekenhuis biedt allerlei voorzieningen die uw bezoek of verblijf plezieriger kunnen maken. Er is een restaurant op de begane grond met een kiosk en u heeft via WiFi gratis toegang tot het internet."

During the past decade, Alrijne Ziekenhuis conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 3 clinical trials were completed, i.e. on average, 13% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 1 clinical trials were completed. i.e. 7.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alrijne Ziekenhuis" #1 sponsor was "Leiden University Medical Center" with 4 trials, followed by "Maastricht University Medical Center" with 4 trials sponsored, "Pfizer" with 2 trials sponsored, "University Medical Center Groningen" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alrijne Ziekenhuis" #1 collaborator was "Borstkanker Onderzoek Groep" with 4 trials as a collaborator, "Dutch Cancer Society" with 4 trials as a collaborator, "Innovatiefonds Zorgverzekeraars" with 3 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 3 trials as a collaborator and "Bronovo Hospital" with 2 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Alrijne Ziekenhuis" are "Breast Neoplasms" (2 trials), "Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials), "Urinary Tract Infection" (2 trials) and "Adjuvant Therapy" (1 trials). Many other conditions were trialed in "Alrijne Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Alrijne Ziekenhuis" are "Drug" (13 trials), "Other" (8 trials), "Device" (5 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "bococizumab (PF-04950615)" (2 trials), "Acetylsalicylic acid" (1 trials), "CDK 4/6 inhibitor" (1 trials) and "Completion axillary treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alrijne Ziekenhuis" are 23 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Alrijne Ziekenhuis". undefined are not yet recruiting, 11 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Alrijne Ziekenhuis, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Alrijne Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 10 trials that are defined as “Not Applicable".